ConductScience.org, home

Paper36745340

New thoughts and findings on invasion and metastasis of pancreatic ductal adenocarcinoma (PDAC) from comparative proteomics: multi-target therapy.

Liu X and 1 other. Clin Transl Oncol, 2023. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. New thoughts and findings on invasion and metastasis of pancreatic ductal adenocarcinoma (PDAC) from comparative proteomics: multi-target therapy. Papers, record 36745340. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36745340

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
New thoughts and findings on invasion and metastasis of pancreatic ductal adenocarcinoma (PDAC) from comparative proteomics: multi-target therapy.
PubMed
Journal
Clin Transl Oncol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.22
iCite
Revised in PubMed
2026-10-31
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu XXinlu
2Li NNahttps://orcid.org/0000-0002-6454-7684

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pancreatic NeoplasmsMajor topic
Carcinoma, Pancreatic DuctalMajor topic
Humans
Proteomics
Gene Expression Regulation, Neoplastic
Cell Line, Tumor
Tumor Microenvironment

Source PubMed

Download CSV of topics

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135145909CD70 in Thymic Squamous Cell Carcinoma: Potential Diagnostic Markers and Immunotherapeutic Targets.Front Oncol2021https://conductscience.org/library/papers/35145909PubMed
232296755Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer.JNCI Cancer Spectr2020https://conductscience.org/library/papers/32296755PubMed
331900901The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approaches.Cell Oncol (Dordr)2020https://conductscience.org/library/papers/31900901PubMed
420879979Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro.Curr Cancer Drug Targets2010https://conductscience.org/library/papers/20879979PubMed
527845903Myoferlin is a novel exosomal protein and functional regulator of cancer-derived exosomes.Oncotarget2016https://conductscience.org/library/papers/27845903PubMed
617496331Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer.Mol Cell Proteomics2007https://conductscience.org/library/papers/17496331PubMed
722898815Matrix metalloproteinase-2 cleavage of the β1 integrin ectodomain facilitates colon cancer cell motility.J Biol Chem2012https://conductscience.org/library/papers/22898815PubMed
821136992Profiling the potential biomarkers for cell differentiation of pancreatic cancer using iTRAQ and 2-D LC-MS/MS.Proteomics Clin Appl2009https://conductscience.org/library/papers/21136992PubMed
927620951The bad seed: Cancer stem cells in tumor development and resistance.Drug Resist Updat2016https://conductscience.org/library/papers/27620951PubMed
1023851313iTRAQ-based quantitative proteomics reveals myoferlin as a novel prognostic predictor in pancreatic adenocarcinoma.J Proteomics2013https://conductscience.org/library/papers/23851313PubMed
1110810361Different expression of CD44, ICAM-1, and HSP60 on primary tumor and metastases of a human pancreatic carcinoma growing in scid mice.Anticancer Res2000https://conductscience.org/library/papers/10810361PubMed
1231591367Extracellular Matrix Alterations in Metastatic Processes.Int J Mol Sci2019https://conductscience.org/library/papers/31591367PubMed
1319369584Interaction between HSP60 and beta-catenin promotes metastasis.Carcinogenesis2009https://conductscience.org/library/papers/19369584PubMed
1435493073Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View.Front Cell Dev Biol2022https://conductscience.org/library/papers/35493073PubMed
1528101591Functions of Cancer-Derived Extracellular Vesicles in Immunosuppression.Arch Immunol Ther Exp (Warsz)2017https://conductscience.org/library/papers/28101591PubMed
1630668176Molecular intricacies of aerobic glycolysis in cancer: current insights into the classic metabolic phenotype.Crit Rev Biochem Mol Biol2018https://conductscience.org/library/papers/30668176PubMed
1732768595Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis.Gastroenterology2020https://conductscience.org/library/papers/32768595PubMed
1822050456Proteomic analysis reveals Warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells.J Proteome Res2012https://conductscience.org/library/papers/22050456PubMed
1925428807Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer.Mol Cancer2014https://conductscience.org/library/papers/25428807PubMed
2031050378Identification and Quantification of Proteoforms by Mass Spectrometry.Proteomics2019https://conductscience.org/library/papers/31050378PubMed

See all 54 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
41024179Engineered exosomes: a promising approach for overcoming challenges in pancreatic cancer therapy.J Nanobiotechnology2025https://conductscience.org/library/papers/41024179PubMed
40616159The type I collagen paradox in PDAC progression: microenvironmental protector turned tumor accomplice.J Transl Med2025https://conductscience.org/library/papers/40616159PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36745340

GET https://conductscience.org/api/papers/v1/36745340/references?page=2